MAXIMIZE MEDICAL MANAGEMENT OF XHANCE
When patients remain symptomatic after standard intranasal corticosteroid sprays, choose XHANCE next in a stepped-care approach to treat nasal polyps1
The “Multidisciplinary Consensus on a Stepwise Treatment Algorithm for Management of Chronic Rhinosinusitis With Nasal Polyps” includes EDS-FLU, marketed as XHANCE, as a treatment option distinct from standard intranasal corticosteroid sprays.1
Important Information: This publication was not funded by Optinose. Some of the authors have been separately engaged by Optinose for clinical research, consulting, or speaking.
See where XHANCE is recommended as an option in the treatment algorithm
SELECT PATIENT STATUS:
- My patient has symptoms consistent with nasal polyps
- My patient may need escalation of treatment
- See full algorithm
AERD=aspirin-exacerbated respiratory disease; ASA=acetylsalicylic acid (aspirin); CBC=complete blood count; CT=computerized tomography scan; EDS-FLU=exhalation delivery system with fluticasone; IgE=immunoglobulin E; INS=intranasal steroids; OCS=oral corticosteroids; QoL=quality of life
AERD=aspirin-exacerbated respiratory disease; ASA=acetylsalicylic acid (aspirin); CBC=complete blood count; CT=computerized tomography scan; EDS-FLU=exhalation delivery system with fluticasone; IgE=immunoglobulin E; INS=intranasal steroids; OCS=oral corticosteroids; QoL=quality of life.